Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026)

Repligen's (RGEN) quarterly Other Non-Current Liabilities came in at $17.1 million in Q2 2026, up 1.31% year-over-year from $16.9 million in Q2 2025, and up 2.0% quarter-over-quarter from $16.8 million in Q1 2026.

Analysis

Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Repligen (RGEN) has reported Other Non-Current Liabilities for 16 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 1.31% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $17.1 million, a 1.31% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, down 57.72% from the prior year.
  • Other Non-Current Liabilities was $17.1 million for Q2 2026 at Repligen, up from $16.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $69.1 million in Q3 2022 and troughed at $11.3 million in Q1 2024.
  • A 5-year average of $29.7 million and a median of $17.1 million in 2025 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities jumped 4515.7% in 2022 and slumped 80.1% in 2023, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $51.6 million in 2022, then tumbled by 72.71% to $14.1 million in 2023, then jumped by 161.46% to $36.8 million in 2024, then sank by 57.72% to $15.6 million in 2025, then increased by 9.87% to $17.1 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $17.1 million (Q2 2026), $16.8 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.09 Mn
Mar 31, 2026 16.76 Mn
Dec 31, 2025 15.56 Mn
Sep 30, 2025 17.32 Mn
Jun 30, 2025 16.87 Mn
Mar 31, 2025 17.08 Mn
Dec 31, 2024 36.79 Mn
Sep 30, 2024 11.61 Mn
Jun 30, 2024 11.48 Mn
Mar 31, 2024 11.28 Mn
Dec 31, 2023 14.07 Mn
Sep 30, 2023 13.76 Mn
Jun 30, 2023 44.28 Mn
Mar 31, 2023 38.91 Mn
Dec 31, 2022 51.56 Mn
Sep 30, 2022 69.14 Mn
Jun 30, 2022 67.90 Mn
Mar 31, 2022 64.04 Mn
Dec 31, 2021 94.24 Mn
Sep 30, 2021 79.96 Mn